| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851530 | American Journal of Kidney Diseases | 2008 | 10 Pages |
Abstract
It is feasible to study MMF as an adjunctive therapy to retard the progression of kidney disease in children with congenital uropathies. A multicenter randomized clinical trial is warranted to determine the efficacy of this novel treatment strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Howard MD, Erica RN, Rachel RN, Josephine MD, Christopher MD, Eduardo MD, Lynne MD, Freya Tarapore, Sherwin Fortune, Judah Horowitz,